159 related articles for article (PubMed ID: 38928024)
1. Genetic Modifiers of Stroke in Patients with Sickle Cell Disease-A Scoping Review.
Oni MO; Brito M; Rotman C; Archer NM;
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928024
[TBL] [Abstract][Full Text] [Related]
2. The search for genetic modifiers of disease severity in the β-hemoglobinopathies.
Lettre G
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028136
[TBL] [Abstract][Full Text] [Related]
3. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
[TBL] [Abstract][Full Text] [Related]
4. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
Menzel S; Thein SL
Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Kirkham JK; Estepp JH; Weiss MJ; Rashkin SR
JAMA Netw Open; 2023 Oct; 6(10):e2337484. PubMed ID: 37851445
[TBL] [Abstract][Full Text] [Related]
6. Defining stroke risks in sickle cell anemia.
Meschia JF; Pankratz VS
Nat Genet; 2005 Apr; 37(4):340-1. PubMed ID: 15800645
[No Abstract] [Full Text] [Related]
7. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia.
Sebastiani P; Ramoni MF; Nolan V; Baldwin CT; Steinberg MH
Nat Genet; 2005 Apr; 37(4):435-40. PubMed ID: 15778708
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variants Associated with the Risk of Stroke in Sickle Cell Anemia: Systematic Review and Meta-Analysis.
Kumari A; Chauhan G; Chaudhuri PK; Kumari S; Prasad A
Hemoglobin; 2024 Mar; 48(2):101-112. PubMed ID: 38637280
[TBL] [Abstract][Full Text] [Related]
9. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
10. Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania.
Nkya S; Mwita L; Mgaya J; Kumburu H; van Zwetselaar M; Menzel S; Mazandu GK; Sangeda R; Chimusa E; Makani J
BMC Med Genet; 2020 Jun; 21(1):125. PubMed ID: 32503527
[TBL] [Abstract][Full Text] [Related]
11. Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.
Mtatiro SN; Singh T; Rooks H; Mgaya J; Mariki H; Soka D; Mmbando B; Msaki E; Kolder I; Thein SL; Menzel S; Cox SE; Makani J; Barrett JC
PLoS One; 2014; 9(11):e111464. PubMed ID: 25372704
[TBL] [Abstract][Full Text] [Related]
12. Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.
Bao EL; Lareau CA; Brugnara C; Fulcher IR; Barau C; Moutereau S; Habibi A; Badaoui B; Berkenou J; Bartolucci P; Galactéros F; Platt OS; Mahaney M; Sankaran VG
Am J Hematol; 2019 May; 94(5):522-527. PubMed ID: 30680775
[TBL] [Abstract][Full Text] [Related]
13. The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.
Adekile A
Med Princ Pract; 2021; 30(3):201-211. PubMed ID: 32892201
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
[TBL] [Abstract][Full Text] [Related]
15. The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia.
Amlie-Lefond C; Flanagan J; Kanter J; Dobyns WB
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2897-2904. PubMed ID: 30076115
[TBL] [Abstract][Full Text] [Related]
16. Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.
Thein SL
Adv Exp Med Biol; 2017; 1013():27-57. PubMed ID: 29127676
[TBL] [Abstract][Full Text] [Related]
17. Genetic Modifiers of Sickle Cell Disease.
Pincez T; Ashley-Koch AE; Lettre G; Telen MJ
Hematol Oncol Clin North Am; 2022 Dec; 36(6):1097-1124. PubMed ID: 36400533
[TBL] [Abstract][Full Text] [Related]
18. Genetic association studies in β-hemoglobinopathies.
Thein SL
Hematology Am Soc Hematol Educ Program; 2013; 2013():354-61. PubMed ID: 24319204
[TBL] [Abstract][Full Text] [Related]
19. [Genetic modifiers of homozygous sickle cell disease].
Hartmann K; Kulozik AE
Klin Padiatr; 2006; 218(3):170-3. PubMed ID: 16688674
[TBL] [Abstract][Full Text] [Related]
20. Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease.
Green NS; Barral S
Pediatr Blood Cancer; 2011 Feb; 56(2):177-81. PubMed ID: 20830771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
